← back to search

Neal D. Freedman

Division of Program Coordination Planning and Strategic Initiatives ·
Area of research
Epidemiology · Surgery
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Esophageal Cancer Research and Treatment, Nutritional Studies and Diet, and Smoking Behavior and Cessation.
h-index
102
citations
40,334
works
1,083
NIH funding
primary concept
email

Recent publications

Oral Microbiome Profile of the US Population
JAMA Network Open 2025cited by 25position: middledoi
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
JAMA Oncology 2025cited by 16position: middledoi
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups
Nature Genetics 2025cited by 9position: middledoi
Association between socioeconomic position and lung cancer incidence in 16 countries: a prospective cohort consortium study
EClinicalMedicine 2025cited by 6position: middledoi
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer
JAMA Oncology 2024cited by 39position: middledoi
Altered salivary microbiota associated with high-sugar beverage consumption
Scientific Reports 2024cited by 16position: middledoi
<i>Helicobacter hepaticus</i> and <i>Helicobacter bilis</i> in liver and biliary cancers from ATBC and PLCO
Helicobacter 2024cited by 6position: middledoi
OA17.06 Impact of Using Smoking Duration in Place of Pack-Years as Eligibility Criteria for Lung Cancer Screening to Reduce Racial and Ethnic Disparities
Journal of Thoracic Oncology 2024cited by 0position: middledoi
Genetically adjusted PSA levels for prostate cancer screening
Nature Medicine 2023cited by 75position: middledoi
The blood proteome of imminent lung cancer diagnosis
Nature Communications 2023cited by 74position: middledoi
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights
European Urology 2023cited by 71position: middledoi
Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US
JAMA Oncology 2023cited by 64position: middledoi
Outdoor Ultrafine Particulate Matter and Risk of Lung Cancer in Southern California
American Journal of Respiratory and Critical Care Medicine 2023cited by 23position: middledoi
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools
JNCI Journal of the National Cancer Institute 2023cited by 21position: middledoi
Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis
International Journal of Epidemiology 2023cited by 18position: middledoi
A metabolomic investigation of serum perfluorooctane sulfonate and perfluorooctanoate
Environment International 2023cited by 16position: middledoi
A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium
Scientific Reports 2023cited by 15position: middledoi
Endogenous sex steroid hormones and risk of liver cancer among US men: Results from the Liver Cancer Pooling Project
JHEP Reports 2023cited by 14position: middledoi
Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding
The American Journal of Human Genetics 2023cited by 11position: middledoi
Association of tea and coffee consumption and biliary tract cancer risk: The Biliary Tract Cancers Pooling Project
Hepatology 2023cited by 9position: middledoi
Inflated expectations: Rare-variant association analysis using public controls
PLoS ONE 2023cited by 9position: middledoi
Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
Cancer Epidemiology Biomarkers & Prevention 2023cited by 6position: middledoi
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
International Journal of Epidemiology 2022cited by 55position: middledoi
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia
International Journal of Cancer 2022cited by 50position: middledoi
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium
Journal of Clinical Oncology 2022cited by 47position: middledoi
Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study
JNCI Cancer Spectrum 2022cited by 45position: middledoi
Representative oral microbiome data for the US population: the National Health and Nutrition Examination Survey
The Lancet Microbe 2022cited by 32position: middledoi
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program
Annals of Epidemiology 2022cited by 31position: middledoi
Circulating bile acid concentrations and non‐alcoholic fatty liver disease in Guatemala
Alimentary Pharmacology & Therapeutics 2022cited by 28position: middledoi
Tobacco Smoking and Risk of Second Primary Lung Cancer
Journal of Thoracic Oncology 2021cited by 130position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christian C. Abnet · National Institutes of Health10 papers (2012–2025)Wen‐Yi Huang · National Cancer Institute9 papers (2017–2025)Richard B. Hayes · NYU Langone Health8 papers (2016–2025)Susan M. Gapstur · Tiffin University7 papers (2013–2019)Jiyoung Ahn · New York University7 papers (2017–2025)Mark P. Purdue · Government of the United States of America6 papers (2017–2023)Brandilyn A. Peters · New York University5 papers (2017–2024)Farin Kamangar · Morgan State University5 papers (2012–2015)Caroline Y. Um · American Cancer Society4 papers (2018–2025)Mary H. Ward · National Institutes of Health4 papers (2012–2023)Weimin Ye · Fujian Medical University4 papers (2012–2015)Harvey A. Risch · Dana-Farber Cancer Institute4 papers (2012–2015)Thomas L. Vaughan · Columbia University4 papers (2012–2015)Marilie D. Gammon · University of North Carolina at Chapel Hill4 papers (2012–2015)David C. Whiteman · University of Edinburgh4 papers (2012–2015)Leslie Bernstein · Beckman Research Institute4 papers (2012–2015)Julia Butt · German Cancer Research Center4 papers (2014–2024)Eric J. Jacobs · Center for Cancer Research4 papers (2014–2018)Liam Murray · University of Massachusetts Chan Medical School4 papers (2012–2015)Anna H. Wu · University of Southern California4 papers (2012–2015)